Homozygosity for a stop-gain variant in CCDC201 causes primary ovarian insufficiency
- PMID: 39192094
- PMCID: PMC11387189
- DOI: 10.1038/s41588-024-01885-6
Homozygosity for a stop-gain variant in CCDC201 causes primary ovarian insufficiency
Abstract
Age at menopause (AOM) has a substantial impact on fertility and disease risk. While many loci with variants that associate with AOM have been identified through genome-wide association studies (GWAS) under an additive model, other genetic models are rarely considered1. Here through GWAS meta-analysis under the recessive model of 174,329 postmenopausal women from Iceland, Denmark, the United Kingdom (UK; UK Biobank) and Norway, we study low-frequency variants with a large effect on AOM. We discovered that women homozygous for the stop-gain variant rs117316434 (A) in CCDC201 (p.(Arg162Ter), minor allele frequency ~1%) reached menopause 9 years earlier than other women (P = 1.3 × 10-15). The genotype is present in one in 10,000 northern European women and leads to primary ovarian insufficiency in close to half of them. Consequently, homozygotes have fewer children, and the age at last childbirth is 5 years earlier (P = 3.8 × 10-5). The CCDC201 gene was only found in humans in 2022 and is highly expressed in oocytes. Homozygosity for CCDC201 loss-of-function has a substantial impact on female reproductive health, and homozygotes would benefit from reproductive counseling and treatment for symptoms of early menopause.
© 2024. The Author(s).
Conflict of interest statement
Authors affiliated with deCODE genetics/Amgen declare competing interests as employees. The remaining authors declare no competing interests.
Figures
Similar articles
-
Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health.Hum Reprod. 2016 Feb;31(2):473-81. doi: 10.1093/humrep/dev318. Epub 2016 Jan 4. Hum Reprod. 2016. PMID: 26732621 Free PMC article.
-
Lessons from Genome-Wide Association Studies in Reproductive Medicine: Menopause.Semin Reprod Med. 2016 Jul;34(4):215-23. doi: 10.1055/s-0036-1585404. Epub 2016 Aug 11. Semin Reprod Med. 2016. PMID: 27513022 Review.
-
FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.Hum Reprod. 2018 May 1;33(5):954-966. doi: 10.1093/humrep/dey057. Hum Reprod. 2018. PMID: 29617818
-
Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation.Fertil Steril. 2021 Sep;116(3):843-854. doi: 10.1016/j.fertnstert.2021.04.021. Epub 2021 May 18. Fertil Steril. 2021. PMID: 34016428 Free PMC article.
-
Genetics of Early and Normal Menopause.Semin Reprod Med. 2015 Nov;33(6):377-83. doi: 10.1055/s-0035-1567825. Epub 2015 Nov 16. Semin Reprod Med. 2015. PMID: 26569518 Review.
References
-
- Snaebjarnarson, A. S. et al. Complex effects of sequence variants on lipid levels and coronary artery disease. Cell186, 4085–4099 (2023). - PubMed
-
- Te Velde, E. R. & Pearson, P. L. The variability of female reproductive ageing. Hum. Reprod. Update8, 141–154 (2002). - PubMed
-
- Stuenkel, C. A. & Gompel, A. Primary ovarian insufficiency. N. Engl. J. Med.388, 154–163 (2023). - PubMed
-
- Lambalk, C. B., van Disseldorp, J., de Koning, C. H. & Broekmans, F. J. Testing ovarian reserve to predict age at menopause. Maturitas63, 280–291 (2009). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
